Cargando…
Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction
It is difficult to achieve minimally invasive injectable cell delivery while maintaining high cell retention and animal survival for in vivo stem cell therapy of myocardial infarction. Here we show that pluripotent stem cell aggregates pre-differentiated into the early cardiac lineage and encapsulat...
Autores principales: | Zhao, Shuting, Xu, Zhaobin, Wang, Hai, Reese, Benjamin E., Gushchina, Liubov V., Jiang, Meng, Agarwal, Pranay, Xu, Jiangsheng, Zhang, Mingjun, Shen, Rulong, Liu, Zhenguo, Weisleder, Noah, He, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095349/ https://www.ncbi.nlm.nih.gov/pubmed/27786170 http://dx.doi.org/10.1038/ncomms13306 |
Ejemplares similares
-
A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of therasnostic agents
por: Wang, Hai, et al.
Publicado: (2015) -
Erratum: A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents
por: Wang, Hai, et al.
Publicado: (2016) -
Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies
por: Malecki, Marek, et al.
Publicado: (2014) -
Supramolecular hydrogels encapsulating bioengineered mesenchymal stem cells for ischemic therapy
por: Hwang, Byung Woo, et al.
Publicado: (2018) -
Targeting Capabilities of Native and Bioengineered Extracellular Vesicles for Drug Delivery
por: Frolova, Liubov, et al.
Publicado: (2022)